AK Medical Holdings Limited (HKG:1789)
4.870
+0.040 (0.83%)
Sep 30, 2026, 4:08 PM HKT
AK Medical Holdings Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, AK Medical Holdings stock has a consensus rating of "Strong Buy" and an average price target of $7.82. The average 1-year stock price forecast is 60.57% higher than the current stock price, while the lowest is $7.01 (+43.94%) and the highest is $8.44 (+73.31%).
Price Target: $7.82 (+60.57%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Sep 1, 2026.
Analyst Ratings
The average analyst rating for AK Medical Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $36.40 | Buy | Maintains | $36.40 | +647.43% | Sep 1, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $7.63 | Buy | Maintains | $7.63 | +56.67% | Aug 29, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $7.60 | Buy | Maintains | $7.60 | +56.06% | Aug 27, 2026 |
Financial Forecast
Revenue This Year
1.65B
from 1.48B
Increased by 11.06%
Revenue Next Year
1.83B
from 1.65B
Increased by 10.86%
EPS This Year
0.37
from 0.30
Increased by 22.11%
EPS Next Year
0.42
from 0.37
Increased by 12.84%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.